1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow Pmm2-CDG: new trials by email Literature Review of Pmm2-CDG trials Research Report on Pmm2-CDG
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| 24-Week Study to Assess the PD, Safety, Tolerability, and PK of GLM101 in Participants With PMM2-CDG GLM101 - Pmm2-CDG, Phosphomannomutase 2 Deficiency | Phase 2 | Completed | Glycomine, Inc. | 27 | 2022-11-29 | 2025-12-17 |
Congenital disorder of glycosylation type 1A (1)
Glycomine, Inc. (1)
Spain (1) · United Kingdom (1) · United States (1)